osimertinib,gefitinib
Astrazeneca
['apple trial']
great presentation of at the #esmo2022 on the long waited results of the apple trial. serial monitoring with liquid biopsy is feasible and can favor early treatment switch. further confirmation of the predictive role of ctdna clearance during egfr tki 
Medical Oncologist at A.O. Papardo, Messina (Italy)